Headline RoundupAugust 6th, 2020

Polarization Distorts Views of Hydroxychloroquine, Healthcare

Summary from the AllSides News Team

Hydroxychloroquine, the anti-malarial drug once touted by President Donald Trump as a potential COVID-19 coronavirus cure, remains a point of contention more than four months into the pandemic. This week, Trump and White House trade adviser Peter Navarro each defended their support for the drug to reporters. Some officials are pushing for more investment and research into hydroxychloroquine; others worry that focusing on the drug could crowd out investment into other potential COVID-19 treatments. The hydroxychloroquine controversy has been covered by news outlets on all sides. Some coverage from left-rated outlets framed Trump administration support for the drug as questionable. Coverage of the drug's effectiveness is more nuanced, as journalists attempt to explain complex medical studies. However, evidence supporting hydroxychloroquine tends to be found in right-rated outlets, while evidence against the drug tends to be found in left-rated outlets.

Featured Coverage of this Story

More headline roundups

AllSides Picks

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right